On this page
Thomas Cusack
Insider
First SEC filing: Feb. 3, 2026 · Latest: Feb. 3, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | HRTX | A | 53,960 | · | · | 53,960 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 8, 2025 | HRTX | A | 227,272 | $1.10 | $249,999 | 227,272 Direct | · | Acquired | -68.4% (price as of 2026-10-02) |
| Nov. 8, 2025 | HRTX | A | 37,879 | · | · | 37,879 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 8, 2025 | HRTX | Stock Option (Right to Buy) | Common Stock | $1.10 | Nov. 8, 2035 | 227,272 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).